Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis
Na-Ra Han, Hi-Joon Park, Seong-Gyu Ko, Phil-Dong Moon, Diana Marcela Aragon Novoa, Fátima Regina Mena Barreto Silva · 2024
Read Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis by Na-Ra Han, Hi-Joon Park, Seong-Gyu Ko, Phil-Dong Moon, Diana Marcela Aragon Novoa, Fátima Regina Mena Barreto Silva (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11643981.txt.
Description
Na-Ra Han and others put out a 2024 lab study of a plant compound that calms swelling. The compound, tryptanthrin, comes from indigo plants. It hit a signaling protein sent out by neutrophils. That protein drives several swelling responses. Two cell systems were used for testing.
Human-like neutrophil cells were triggered by chemicals. Mouse bone marrow neutrophils backed the effect. The compound lowered the protein's output and gene activity. It blocked a three-step signaling chain inside the cells. Less of that signal means possible therapy value. Natural compounds with defined ways deserve work as future drugs.
Catalog record
| CREATOR | Na-Ra Han, Hi-Joon Park, Seong-Gyu Ko, Phil-Dong Moon, Diana Marcela Aragon Novoa, Fátima Regina Mena Barreto Silva |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |